Pauling, John D.
Nagaraja, Vivek
Khanna, Dinesh
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24 AR06312)
Article History
First Online: 27 February 2019
Compliance with Ethical Standards
:
: Dr. Khanna reports personal fees from Actelion, Astra Zeneca, Chemomab, Civi Biopharma, Corbus, CSL Behring, Cytori, Eicos, EMD, Serono, GSK and Horizon; grants and personal fees from Bayer, BMS, Boehringer-Ingelheim, Genetech/Roche, Sanofi-Aventis/Genzy and UCB Pharma; and grants from NIH NIAID, NIH NIAMS and Pfizer, during the conduct of the study, outside the submitted work.Dr. Pauling reports grants, personal fees and other from Actelion pharmaceuticals, personal fees from Boehringer Ingelheim, outside the submitted work.Dr. Vivek Nagaraja has nothing to disclose.
: This article does not contain any studies with human or animal subjects performed by any of the authors.